Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients

World Journal of Gastroenterology

Volumn 20, Issue 32, 2014, Pages 11340-11346

  Wang, Li Li ^a   Du, Lu Tao ^a   Li, Juan ^a   Liu, Yi Min ^a   Qu, Ai Lin ^a   Yang, Yong Mei ^a   Zhang, Xin ^a   Zheng, Gui Xi ^a   Wang, Chuan Xin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Biomarker; Colorectal cancer; MicroRNA 133a; Prognosis; Real time polymerase chain reaction

Indexed keywords

MICRORNA; MICRORNA 133A; UNCLASSIFIED DRUG; MIRN133 MICRORNA, HUMAN; TUMOR MARKER;

ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CANCER; COMPARATIVE STUDY; CORRELATIONAL STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR INVASION; VERY ELDERLY; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TIME; TREATMENT OUTCOME; TUMOR VOLUME;

CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84909582592     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i32.11340     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2010; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2011; 60 : 277-300 [PMID: 20610543 DOI: 10.3322/caac.20073]
3. Duffy MJ, Lamerz R, Haglund C, Nicolini A, Kalousová M, Holubec L, Sturgeon C. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer 2014; 134: 2513-2522 [PMID: 23852704 DOI: 10.1002/ ijc.28384]
4. Ma Y, Zhang P, Yang J, Liu Z, Yang Z, Qin H. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int J Cancer 2012; 130: 2077-2087 [PMID: 21671476 DOI: 10.1002/ ijc.26232]
5. Moriya Y, Nohata N, Kinoshita T, Mutallip M, Okamoto T, Yoshida S, Suzuki M, Yoshino I, Seki N. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. J Hum Genet 2012; 57: 38-45 [PMID: 22089643 DOI: 10.1038/jhg.2011.126]
6. Wu ZS, Wang CQ, Xiang R, Liu X, Ye S, Yang XQ, Zhang GH, Xu XC, Zhu T, Wu Q. Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer 2012; 12: 51 [PMID: 22292984 DOI: 10.1186/1471-2407-12-51]
7. Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama K, Nohata N, Seki N, Nakagawa M. The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer 2012; 48: 827-836 [PMID: 21745735 DOI: 10.1016/ j.ejca.2011.06.030]
8. Kojima S, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nohata N, Fuse M, Ichikawa T, Naya Y, Nakagawa M, Seki N. Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J Cancer 2012; 106: 405-413 [PMID: 22068816 DOI: 10.1038/bjc.2011.462]
9. Song T, Xia W, Shao N, Zhang X, Wang C, Wu Y, Dong J, Cai W, Li H. Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev 2010; 11: 905-911 [PMID: 21133599]
10. Chen WS, Leung CM, Pan HW, Hu LY, Li SC, Ho MR, Tsai KW. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer. Oncol Rep 2012; 28: 1069-1076 [PMID: 22766685 DOI: 10.3892/or.2012.1899]
11. Dong Y, Zhao J, Wu CW, Zhang L, Liu X, Kang W, Leung WW, Zhang N, Chan FK, Sung JJ, Ng SS, Yu J. Tumor suppressor functions of miR-133a in colorectal cancer. Mol Cancer Res 2013; 11: 1051-1060 [PMID: 23723074 DOI: 10.1158/1541-7786.MCR-13-0061]
12. Wang H, An H, Wang B, Liao Q, Li W, Jin X, Cui S, Zhang Y, Ding Y, Zhao L. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur J Cancer 2013; 49: 3924-3935 [PMID: 23968734 DOI: 10.1016/j.ejca.2013.07]
13. Li Z, Gu X, Fang Y, Xiang J, Chen Z. microRNA expression profiles in human colorectal cancers with brain metastases. Oncol Lett 2012; 3: 346-350 [PMID: 22740910]
14. Nohata N, Hanazawa T, Enokida H, Seki N. microRNA- 1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 2012; 3: 9-21 [PMID: 22308266]
15. Nelson KM, Weiss GJ. MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther 2008; 7: 3655-3660 [PMID: 19074842 DOI: 10.1158/1535-7163.MCT-08-0586]
16. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610 [PMID: 20661255 DOI: 10.1038/nrg2843]
17. Davis-Dusenbery BN, Hata A. MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways. Genes Cancer 2010; 1: 1100-1114 [PMID: 21533017 DOI: 10.1177/1947601910396213]
18. Liu GH, Zhou ZG, Chen R, Wang MJ, Zhou B, Li Y, Sun XF. Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer. Tumour Biol 2013; 34 : 2175-2181 [PMID: 23625654 DOI: 10.1007/s13277-013-0753-8]
19. Yu H, Gao G, Jiang L, Guo L, Lin M, Jiao X, Jia W, Huang J. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol 2013; 6: 2904-2911 [PMID: 24294377]
20. Zhou Y, Feng X, Liu YL, Ye SC, Wang H, Tan WK, Tian T, Qiu YM, Luo HS. Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways. PLoS One 2013; 8: e81203 [PMID: 24312276 DOI: 10.1371/journal.pone.0081203]
21. Hamara K, Bielecka-Kowalska A, Przybylowska-Sygut K, Sygut A, Dziki A, Szemraj J. Alterations in expression profile of iron-related genes in colorectal cancer. Mol Biol Rep 2013; 40 : 5573-5585 [PMID: 24078156 DOI: 10.1007/ s11033-013-2659-3]
22. Suzuki S, Yokobori T, Tanaka N, Sakai M, Sano A, Inose T, Sohda M, Nakajima M, Miyazaki T, Kato H, Kuwano H. CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma. Oncol Rep 2012; 28: 465-472 [PMID: 22641236 DOI: 10.3892/or.2012.1831]
23. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 2010; 102: 883-891 [PMID: 20160723 DOI: 10.1038/ sj.bjc.6605570]
24. Uchida Y, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Kawahara K, Nishiyama K, Seki N, Nakagawa M. MiR- 133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol Oncol 2013; 31: 115-123 [PMID: 21396852 DOI: 10.1016/j.urolonc.2010.09.017]
25. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 2011; 104: 808-818 [PMID: 21304530 DOI: 10.1038/bjc.2011.23]